FDA Permits Marketing of Digital Game to Improve Attention in ADHD Children (2020)
luu Thursday, October 31, 2024
Summary
The linked article is about the FDA's approval of the first game-based digital therapeutic to improve attention function in children with ADHD. The FDA has permitted the marketing of EndeavorRx, a prescription-only digital therapeutic that uses a game-based approach to improve attention in children aged 8-12 with ADHD. This is the first game-based therapy to be authorized by the FDA for this purpose, providing an alternative treatment option for managing ADHD symptoms in children.
41
19
Summary
fda.gov